| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/09/2001 | WO2001002017A3 Erythropoietin conjugates with polyethylenglycol |
| 08/09/2001 | WO2000078938A9 Molecular modeling for metalloproteins |
| 08/09/2001 | WO2000078921A3 Shank proteins and methods of use thereof |
| 08/09/2001 | WO2000077216A3 Porcine circovirus vaccine in recombinant poxvirus |
| 08/09/2001 | WO2000073324A9 Modulation of gene expression in gastrointestinal inflammation |
| 08/09/2001 | WO2000070046A9 Secreted polypeptides and corresponding polynucleotides |
| 08/09/2001 | WO2000069895A3 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
| 08/09/2001 | WO2000064941A3 G-protein coupled receptor and method of using same |
| 08/09/2001 | WO2000060103A3 Dna construct comprising a cyanophage of cyanobacteria promoter and its use |
| 08/09/2001 | WO2000058510A3 Schizophrenia associated genes, proteins and biallelic markers |
| 08/09/2001 | WO2000050452A9 Mutants of rac protein |
| 08/09/2001 | WO2000043494A9 Control of virus infection using replication associated proteins, compositions and methods of use |
| 08/09/2001 | WO2000037643A3 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 08/09/2001 | WO2000006713A3 Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin |
| 08/09/2001 | US20010012890 Administering caveolin antibody nucleic acid |
| 08/09/2001 | US20010012889 36 human secreted proteins |
| 08/09/2001 | US20010012888 Compounds for diagnosis of tuberculosis and methods of their use |
| 08/09/2001 | US20010012887 Cloning and uses of the genetic locus bcl-6 |
| 08/09/2001 | US20010012831 Calcium-binding protein |
| 08/09/2001 | US20010012628 sbgFGF-19a |
| 08/09/2001 | US20010012627 Neurotransmitter transporter SC6 |
| 08/09/2001 | US20010012626 Polynucleotides encoding Presenilin 1 (PS1); diagnosing a patient having an increased likelihood of contracting Alzheimer's disease |
| 08/09/2001 | US20010012625 Ngf variants |
| 08/09/2001 | US20010012624 Polynucleotides, vectors, host cells; for research, diagnosis and clinical use |
| 08/09/2001 | US20010012621 Determining the expression of lysyl oxidase, the expression of lysyl oxidase indicating that the compound is capable of suppressing ras functions |
| 08/09/2001 | US20010012512 Non-virulent porphyromonas gingivalis mutant |
| 08/09/2001 | US20010012506 Endothelial-derived toxic factor |
| 08/09/2001 | EP1144611A3 Method for recombinant protein production in mammalian cells comprising co-expression with fetuin |
| 08/09/2001 | DE19949184A1 Verfahren zur Bestimmung von verschiedenen Typen von Autoantikörpern gegen den TSH-Rezeptor durch selektive Immunpräzipitation, Fusionsproteine zur Durchführung eines solchen Verfahrens und die Verwendung von markierten TSH-Rezeptor-Chimären bei einem solchen Verfahren A method for the determination of various types of autoantibodies against the TSH receptor by selective immunoprecipitation, Fusion proteins for implementing such a method and the use of labeled TSH receptor chimeras in such a method |
| 08/09/2001 | DE10004930A1 Gene encoding a protein of the G protein receptor super family, having homology to neurotransmitter receptors is useful to develop new medicaments |
| 08/09/2001 | DE10004667A1 Neues ß-Defensin, hBD-3, Herstellung und seine Anwendung New beta-defensin hBD-3, Processing and its Application |
| 08/09/2001 | DE10004456A1 Synthetische Peptide als Strukturelemente einer sich durch Anlagerung (Selbst-Anordnung) der Peptide aneinander aufbauenden geordneten Struktur Synthetic peptides as structural elements by the addition of a (self-assembly) of the peptides together constituting ordered structure |
| 08/09/2001 | CA2400013A1 Methods of protein destabilization and uses thereof |
| 08/09/2001 | CA2399982A1 G-protein coupled receptors |
| 08/09/2001 | CA2399809A1 Combinatorial protein domains |
| 08/09/2001 | CA2399776A1 Novel nucleic acids and polypeptides |
| 08/09/2001 | CA2399686A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | CA2399681A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides |
| 08/09/2001 | CA2399652A1 Methods and materials relating to neuronal guidance molecule-like (ngm-like) polypeptides and polynucleotides |
| 08/09/2001 | CA2399649A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
| 08/09/2001 | CA2399644A1 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 08/09/2001 | CA2399633A1 Novel human membrane proteins and polynucleotides encoding the same |
| 08/09/2001 | CA2399561A1 Ruminant mhc class i-like fc receptors |
| 08/09/2001 | CA2399509A1 Melanin-concentrating hormone analogs |
| 08/09/2001 | CA2399235A1 Method of purifying a hydrophobin present in a hydrophobin-containing solution |
| 08/09/2001 | CA2399080A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 08/09/2001 | CA2399032A1 Ligands for fpr class receptors that induce a host immune response to a pathogen or inhibit hiv infection |
| 08/09/2001 | CA2399026A1 Mucin-1 derived antigens and their use in immunotherapy |
| 08/09/2001 | CA2399022A1 Ligand for vascular endothelial growth factor receptor |
| 08/09/2001 | CA2398877A1 Nucleic acids, proteins, and antibodies |
| 08/09/2001 | CA2398816A1 Human immunodeficiency virus vaccine |
| 08/09/2001 | CA2398255A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | CA2398215A1 Methods and materials relating to preadipocyte factor-1-like (pref-1-like) polypeptides and polynucleotides |
| 08/09/2001 | CA2391209A1 Root transcriptional factors and methods of use |
| 08/09/2001 | CA2369056A1 Vmip-ii peptide antagonists of cxcr4 |
| 08/09/2001 | CA2369050A1 Methods for preventing or attenuating pathoangiogenic conditions |
| 08/08/2001 | EP1122314A1 Method for the production of a protein |
| 08/08/2001 | EP1122313A1 Novel g protein-coupled receptor protein and dna thereof |
| 08/08/2001 | EP1122312A1 Novel protein war-1 and gene thereof |
| 08/08/2001 | EP1122311A1 Remedies for neuropathy containing as the active ingredient galectin-1 or its derivatives |
| 08/08/2001 | EP1122308A1 Method for amplifying foreign gene |
| 08/08/2001 | EP1122262A1 Neovascular-specific peptides |
| 08/08/2001 | EP1121600A2 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections |
| 08/08/2001 | EP1121462A2 Genes for assessing cardiovascular status and compositions for use thereof |
| 08/08/2001 | EP1121457A1 Use of socs-2 or cis to screen for compounds enhancing growth hormone effect |
| 08/08/2001 | EP1121455A1 Zinc finger peptide cleavage of nucleic acids |
| 08/08/2001 | EP1121454A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 08/08/2001 | EP1121448A1 EXPRESSION AND SECRETION OF icIL-1 RECEPTOR ANTAGONIST TYPE II |
| 08/08/2001 | EP1121442A2 Recombinant e1a deleted adenoviral vectors |
| 08/08/2001 | EP1121441A2 Selectively replicating viral vectors |
| 08/08/2001 | EP1121440A2 Improved expression of cry3b insecticidal protein in plants |
| 08/08/2001 | EP1121439A2 Methods and compositions for inhibiting neoplastic cell growth |
| 08/08/2001 | EP1121438A2 p53 BINDING AREAS |
| 08/08/2001 | EP1121437A2 Metastatic breast and colon cancer regulated genes |
| 08/08/2001 | EP1121436A2 Non-desensitizing ampa-receptors |
| 08/08/2001 | EP1121435A1 Camel, an alternative translation product of the tumour antigen lage-1 |
| 08/08/2001 | EP1121434A1 A method of modulating cell survival and reagents useful for same |
| 08/08/2001 | EP1121433A2 Human ankyrin family protein |
| 08/08/2001 | EP1121432A2 G-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 08/08/2001 | EP1121431A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 08/08/2001 | EP1121430A1 Human isre-binding protein |
| 08/08/2001 | EP1121429A2 Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e |
| 08/08/2001 | EP1121428A2 Genes, proteins and biallelic markers related to central nervous system disease |
| 08/08/2001 | EP1121427A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 08/08/2001 | EP1121426A2 Method for triggering apoptosis in cells |
| 08/08/2001 | EP1121425A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 08/08/2001 | EP1121419A1 Tnfr related gene 12 |
| 08/08/2001 | EP1121418A1 A novel lymphocyte population expressing intracellular mo2 |
| 08/08/2001 | EP1121383A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 08/08/2001 | EP1121382A2 Interferon-beta fusion proteins and uses |
| 08/08/2001 | EP1121381A2 Zinc finger binding domains for gnn |
| 08/08/2001 | EP1121380A1 Target of rnaiii activating protein (trap) |
| 08/08/2001 | EP1121379A1 MAMMALIAN elk POTASSIUM CHANNEL GENES |
| 08/08/2001 | EP1121374A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 08/08/2001 | EP1121157A1 A novel component in the hedgehog signalling pathway |
| 08/08/2001 | EP1121156A2 Polymer conjugates of interferon beta- 1a and their uses |
| 08/08/2001 | EP1121155A2 Site-directed dual pegylation of proteins |
| 08/08/2001 | EP1121154A2 Macromolecular active substance conjugates and a method for the production thereof |
| 08/08/2001 | EP1121151A1 Anti-inflammatory alpha2, beta1 integrin-related substances or antibodies |
| 08/08/2001 | EP1121144A1 Stable concentrated insulin preparations for pulmonary delivery |